Published in Health Risk Factor Week, June 3rd, 2008
These two respirators--3M(TM) Particulate Respirator 8612F and 3M(TM) Particulate Respirator 8670F--are unique because they are the first to receive clearance by the U.S. Food & Drug Administration (FDA) to reduce exposure to airborne germs during a public health medical emergency such as an influenza pandemic. The FDA outlined a special clearance process for N95 respirators used by the general public in public health medical emergencies in order to provide reasonable assurance...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Risk Factor Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.